A PROSPECTIVE, RANDOMIZED COMPARATIVE TRIAL OF MIZORIBINE VERSUS MYCOPHENOLATE MOFETIL IN COMBINATION THERAPY WITH TACROLIMUS AND BASILIXIMAB FOR LIVING DONOR RENAL TRANSPLANTATION.
Not Applicable
- Conditions
- Kidney transplantation
- Registration Number
- JPRN-UMIN000009120
- Lead Sponsor
- AMCT
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1.The patient who is pregnant or a female patient who is expecting to become pregnant. 2.The patient who has anti-donor antibody (anti-T antibody). 3.The patient who has severe infections. 5.The patient with whom the physician-in-charge considered inappropriate as a subject of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rejection (incidence, types, severity)
- Secondary Outcome Measures
Name Time Method Patient survival, graft survival, incidence of adverse effects / abnormalities in the laboratory values.